ASND Q3'26 Earnings: revenue estimate is 409.37M USD

ASND (Ascendis Pharma A/S) is set to announce its Q3'26 results on November 11, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 409.37 million USD with EPS (earnings per share) anticipated at 0.89 USD. Learn more details at A…